Impact of Treatments on Radiographic Progression over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort

被引：0
|
作者：
Kedra, Joanna [1 ]
Hajage, David [1 ]
Lafourcade, Alexandre [1 ]
Combe, Bernard [2 ]
Dougados, Maxime [3 ]
Fautrel, Bruno [4 ,5 ]
机构：
[1] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S1136, Paris, France
[2] Univ Montpellier, Montpellier, France
[3] Univ Paris, Dept Rheumatol, Hop Cochin, Paris, France
[4] Sorbonne Univ, INSERM, IPLES, Paris, Ile De France, France
[5] Hop La Pitie Salpetriere, Paris, Ile De France, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1718
引用
收藏
页数：3
相关论文
共 50 条
  • [1] IMPACT OF TREATMENTS ON RADIOGRAPHIC PROGRESSION OVER THE FIRST 10 YEARS OF DISEASE IN EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE ESPOIR COHORT
    Kedra, J.
    Hajage, D.
    Lafourcade, A.
    Combe, B.
    Dougados, M.
    Fautrel, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 261 - 261
  • [2] Impact of Treatments on Favorable Outcome over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from a WCE Model in the ESPOIR Cohort
    Kedra, Joanna
    Hajage, David
    Lafourcade, Alexandre
    Combe, Bernard
    Dougados, Maxime
    Fautrel, Bruno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] IMPACT OF OBESITY ON DISEASE ACTIVITY AND RADIOGRAPHIC PROGRESSION IN A COHORT OF EARLY RHEUMATOID ARTHRITIS: RESULTS FROM ESPOIR COHORT
    Daien, C. I.
    Sellam, J.
    Rincheval, N.
    Fautrel, B.
    Saraux, A.
    Morel, J.
    Daures, J. -P.
    Combe, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 430 - 431
  • [4] Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort
    Rodriguez-Muguruza, S.
    Combe, B.
    Guillemin, F.
    Fautrel, B.
    Olive, A.
    Marsal, S.
    Valero, O.
    Lukas, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (07) : 1361 - 1367
  • [5] Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
    Meyer, Magali
    Sellam, Jeremie
    Fellahi, Soraya
    Kotti, Salma
    Bastard, Jean-Philippe
    Meyer, Olivier
    Liote, Frederic
    Simon, Tabassome
    Capeau, Jacqueline
    Berenbaum, Francis
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [6] Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
    Magali Meyer
    Jérémie Sellam
    Soraya Fellahi
    Salma Kotti
    Jean-Philippe Bastard
    Olivier Meyer
    Frédéric Lioté
    Tabassome Simon
    Jacqueline Capeau
    Francis Berenbaum
    [J]. Arthritis Research & Therapy, 15
  • [7] The Progression of the Rate of Biologic Initiation in Early Rheumatoid Arthritis Is Constant Over the First 5 Years in the Espoir Cohort.
    Emilie, Stephanie
    Gaujoux-Viala, Cecile
    Granger, Benjamin
    Rat, Anne-Christine
    Combe, Bernard
    Fautrel, Bruno
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S782 - S782
  • [8] Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort
    Louveau, Baptiste
    De Rycke, Yann
    Lafourcade, Alexandre
    Saraux, Alain
    Guillemin, Francis
    Tubach, Florence
    Fautrel, Bruno
    Hajage, David
    [J]. RHEUMATOLOGY, 2018, 57 (09) : 1563 - 1573
  • [9] RADIOGRAPHIC PROGRESSION RATES OVER THE FIRST 10 YEARS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW
    Carpenter, Lewis
    Sharpe, Rachel
    Nikiphorou, Elena
    Norton, Sam
    Bunn, Frances
    Scott, David L.
    Young, Adam
    [J]. RHEUMATOLOGY, 2015, 54 : 82 - 82
  • [10] Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis
    Lindqvist, E
    Jonsson, K
    Saxne, T
    Eberhardt, K
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (07) : 611 - 616
12345